Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001193125-26-061885

President & CEO sold 423 shares at $73.00 ($30,879)

From the SEC's structured data for this filing

Trades in this filing

ROBIN HOWARD W · President & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-02-18 Sale : show line 1 in the form −423 $73.00 $30,879 75,489 D
Open-market sales · 423 sh · avg $73.00 · $30,879
Loading xslF345X05/ownership.xml…